Fusion Pharmaceuticals Inc. (37) | Development Agreements (2)
- Master Services Agreement, dated as of February 22, 2017, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant (Filed With SEC on June 5, 2020)
- Supply Agreement, dated as of January 17, 2019, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant (Filed With SEC on June 5, 2020)
